4 Areas where a CDMO can help your Viral Vector project. 10.7.2020 The therapeutic possibilities of cell and gene therapy are very appealing. The possibility to use a Viral Vector to carry the therapeutic gene into the target cells or to initiate cell transduction holds the potential …
Biovian’s new facility for Viral Vector GMP manufacturing is completed 31.3.2020 Biovian has expanded its GMP Viral Vector contract development and manufacturing facilities.
